platinum has been researched along with temozolomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hargis, S; Jiang, Y; Liu, X; Nowak, B; Plunkett, W | 1 |
| Kato, S | 1 |
2 other study(ies) available for platinum and temozolomide
| Article | Year |
|---|---|
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cytarabine; Dacarbazine; DNA Breaks; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Homologous Recombination; Humans; Platinum; Poly (ADP-Ribose) Polymerase-1; Temozolomide; Tumor Suppressor Protein p53 | 2016 |
Effects of platinum-coexisting dopamine with X-ray irradiation upon human glioblastoma cell proliferation.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dopamine; Drug Combinations; Glioblastoma; Humans; Mitosis; Nanoparticles; Neurotransmitter Agents; Phenethylamines; Platinum; Radiation Dosage; Reactive Oxygen Species; Temozolomide; X-Rays | 2021 |